You are here: Industry Insights > COVID-19 Vaccine

News List

Bangladesh signs Covid-19 vaccine deal with Serum Institute of India pharmaceutical-technology
November 09, 2020
Bangladesh has entered into a deal with the Serum Institute of India (SII) to acquire 30 million doses of a potential vaccine being developed by AstraZeneca for Covid-19.
CVnCoV COVID-19 vaccine safely elicits immune response in Phase I testing europeanpharmaceuticalreview
November 06, 2020
The interim Phase I data suggests CVnCoV can safely induce a neutralising antibody response similar to that of convalescent COVID-19 patients with two 12μg vaccine doses.
Australia to acquire 40 million doses of Novavax Covid-19 vaccine pharmaceutical-technology
November 06, 2020
Novavax has signed a non-binding heads of terms document with the Australian Government to supply 40 million doses of its Covid-19 vaccine candidate, NVX-CoV2373.
SCHOTT KAISHA expands vial production capacity for COVID-19 vaccine Rs 105 cr investment expresspharma
November 06, 2020
SCHOTT KAISHA has announced an immediate investment of Rs 105 crores into its existing facilities to increase its vial production by 300 million pieces.
CEPI to fund Clover’s Covid-19 vaccine development pharmaceutical-technology
November 06, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has extended its partnership to fund the development of Sichuan Clover Biopharmaceuticals’ protein-based S-Trimer Covid-19 vaccine candidate.
Aspen Pharmacare to manufacture Covid-19 vaccine candidate with J&J pharmaceutical-technology
November 05, 2020
Aspen’s South African subsidiary Aspen Pharmacare has signed a preliminary agreement with two Johnson & Johnson (J&J) subsidiaries for the technical transfer and proposed commercial manufacture of their Covid-19 vaccine candidate.
Brazil authorises resumption of Johnson & Johnson’s Covid-19 vaccine trial pharmaceutical-technology
November 05, 2020
The Brazilian Health Surveillance Agency Anvisa has granted approval to Johnson & Johnson (J&J) for resuming a clinical trial of its experimental Covid-19 vaccine in the country.
Highly potent nanoparticle COVID-19 vaccine designed using computer europeanpharmaceuticalreview
November 05, 2020
Developers suggest that the potency, stability and manufacturability of the nanoparticle vaccine candidate could enable vaccination against COVID-19 on a global scale.
Thermo King by Trane Technologies launches cold storage solutions for COVID-19 vaccine supply expresspharma
November 04, 2020
The company assures that it can offer temporary storage solutions that maintain a set point down to -70 degrees Celsius, and can ensure end-to-end temperature control solutions.
Ultrapotent COVID-19 vaccine candidate designed via computer worldpharmanews
November 04, 2020
An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page